Novo Nordisk Tumbles in ‘Worst Case Scenario’: Next-Gen Weight Loss Drug Underperforms

Novo Nordisk stock, once the darling of the pharmaceutical world, tumbled as investors reacted to a “worst-case scenario.” 

Importance Rank: 
1

read more